Bitcoin's price dropped 3.2% below its October 1 opening level, trading at $80,867 compared to $83,576 at the start of the month. This decline contrasts with the historical average mid-October gain of 6.7% since 2013. Trendline support is near $80,400, and a confirmed break below this could lead to further drops to $77,000 and below. The recent Consumer Price Index data showing moderate inflation may contribute to uncertainty, with some analysts fearing Bitcoin will remain range-bound in the near term.
Bitcoin's price dropped 3.2% below its October 1 opening level, trading at $80,867 as of Oct 17, 2026 04:51 WIB. For readers following cryptocurrency markets, here is Pluang's market snapshot: out of 50 major cryptocurrencies priced on Pluang, 10 rose and 39 fell today. Notable movers include CRV at Rp6.181 with a 3.96% decrease and 79% sell order activity, SAND at Rp974 down 3.89% with 59% buy order activity, and FIL at Rp20.299 down 3.33% with 79% buy order activity.
Changan Automobile announced new partnerships covering seven European markets and launched its "with U" service program at Mondial de l’Auto 2026. This marks a shift from market entry to building a local ecosystem including manufacturing, sales, serv...
At the 2026 Mondial de l’Auto, Changan Automobile signed letters of intent with eight companies across seven European markets and launched its "with U" service program. This marks a strategic move to build a strong local ecosystem combining manufactu...
Northland Power Inc. announced it will release its third quarter 2026 financial results after market close on November 12, 2026. The company will host an earnings call and webcast on November 13 at 9:00 a.m. ET, providing investors an opportunity to ...
Several daily leveraged ETFs tied to tech and crypto-related stocks dropped sharply, with declines over 20%. Notable falls include GraniteShares 2x Long NBIS Daily ETF down 24.5% and Leverage Shares 2x Long CRWV Daily ETF down 23.9%. These ETFs aim t...
Recent biotech IPOs Iambic Therapeutics and City Therapeutics saw significant price jumps, rising 25.9% and 22.2% respectively after their market debuts, raising substantial capital. Inverse leveraged ETFs SMCZ and SMST also gained sharply as their u...
